345 Park Avenue South

Cure by Deerfield Launches Middle East Health Accelerator in Qatar Image

Blue

News & Insights

Your Home in NYC

Cure Founders Pass Membership Benefits 03 Tab Bar Image

Dark Blue

Become a Member

Where Healthcare Innovators Connect

Magenta

Attend An Event

Accelerating Advances in Health

Green

About

Contact us

### About
Sherri Gordon, CLC, is an award-winning author, journalist, editor, and certified professional life coach.

### Experience 
Gordon specializes in taking complex health and science concepts and turning them into clear, accessible content that is easy to understand. An author of nearly 30 nonfiction books for young readers, her skills earned her an "Outstanding Science Trade Books for Students K-12" award for her book on food allergies.
Gordon also is a freelance health and parenting writer covering health, health news, mental health, social issues, relationships, sleep medicine, allergies, dermatology, parenting, ADHD, autism, and more. Her work has appeared in *Health*, *Parents*, *Understood*, *Verywell Health*, *Verywell Family*, *Verywell Mind*,*Verywell Fit*, *Columbus Parent*, and more. She also is a life coach specializing in helping people address bullying, improve relationships, or focus on self-improvement.

### Education
Gordon earned a Bachelor of Arts from Otterbein University in Westerville, Ohio in public relations and speech communication with a minor in English. She also earned a Certificate of Completion from Ohio State's Patient and Community Peer Review Academy, where she frequently serves as a community reviewer for grant requests for health research. Gordon also is a member of the Association of Health Care Journalists.


Contributing Writer

Most clinical trials fail, and the reasons extend far beyond the science. 

CII-Prelaunch - What's Standing Between a Promising Drug and the Patients Who Need It - Image

What's Standing Between a Promising Drug and the Patients Who Need It?

Federal grants are vanishing and VC dollars are concentrating at the top. For early-stage biotech founders, the path from lab to funding looks nothing like it did five years ago.

Who Is Funding the Science That's Too Early for Venture Capital?

From early IP decisions to FDA strategy and investor negotiations, a biotech company’s legal needs shift quickly as it grows. Here’s how founders can build the right legal foundation, avoid common missteps, and bring in the right counsel at the right time.

The Legal Playbook for Building a Biotech Company, From Formation to Financing

Moving a discovery from the lab to large-scale manufacturing requires far more than a handoff. Experts explain how technology transfer works in biotech and pharma, the different types of transfers, and why poor execution can delay commercialization.

Technology Transfer in Biotech and Pharma and the Process of Scaling New Medicines

Landing a job in biotech takes more than strong science credentials. Recruiters and founders explain what companies look for and how candidates can position themselves to break into the industry.

How to Get a Job in Biotech: A Career Guide for Scientists and Industry Entrants

For biotech startups, patient data is both a competitive edge and a legal risk. Experts explain how to collect, store, and use it responsibly without slowing growth.

Patient Data Is an Asset and a Liability—Here’s How to Avoid Costly Missteps

Patient focus groups can surface powerful insight or quietly mislead early decisions. Experts share tips for biotech teams on how to design and run focus groups that generate real, actionable input while respecting patient autonomy.

Patient Focus Groups Drive Better Research—Here's How to Get Real Insights

Regulators and investors still want clean data, but patients want proof a therapy changes daily life. Here’s how early-stage biotech teams can choose endpoints that are measurable, meaningful, and feasible.

Patient-Centered Endpoints for Biotech Startups: Choosing Outcomes That Matter in the Real World

Experts outline how to assess fit, protect data quality, and decide where decentralization belongs in your clinical trial strategy.

Decentralized Trials 101: How to Decide if a DCT Model Fits Your Study and Keep Data Quality High

Patient advisory boards can inform high-stakes decisions, or erode trust if poorly designed. Experts share how to structure boards that deliver credible insights patients and investors take seriously.

How to Build a Patient Advisory Board That Actually Works in Biotech and Healthcare

From JPM Week and BIO to ASCO, AACR, and HIMSS, these biotech and life sciences events are where founders, investors, and industry leaders will connect and spot emerging trends in 2026.

13 Best Biotech and Life Sciences Conferences Taking Place In 2026

A look at 13 leading biotech venture capital firms backing life sciences startups, from early discovery through commercialization.

13 Leading Biotech Venture Capital Firms Shaping the Industry

A look at 13 startups and public companies advancing genetic medicines, cell-based therapies, and next-generation treatment platforms.

13 Cell and Gene Therapy Companies to Watch in 2026

A look at 11 companies using AI-driven platforms to reshape drug discovery, including generative models, computational chemistry, and data-centric biology.

11 Innovative Companies Using AI for Drug Discovery

Biotech lab experts explain how your early-stage startup can find affordable lab space, evaluate incubators, reduce upfront costs, and choose environments that support long-term growth.

Thumbnail Empty Laboratory DNA Computer Screen

The Biotech Founder’s Guide to Finding Affordable Lab Space That Supports Growth

Two biotech CEOs explain why defining the market size for a new biotech company is essential, and how to build a credible biotech TAM using real data, top-down and bottom-up approaches, and TAM/SAM/SOM.

How to Evaluate the Market Size for a New Biotech Company

Starting a biotech company requires more than groundbreaking research. Experts including Steven Quay, MD, of Atossa Therapeutics, and Katarina Klett, PhD, of QB3 share essential steps founders should follow to move from idea to company formation, patent protection, funding, and regulatory readiness.

How to Start a Biotech Company—11 Key Steps Every Early-Stage Founder Should Follow

Patient engagement is reshaping translational research in biotech. In this article, experts in bioethics and clinical innovation share top strategies for recruiting, involving, and empowering patients early and achieve meaningful, patient-centered solutions.

Patient Engagement Is the Secret to Smarter Research—Here’s How to Nail It

In this fifth of five installments in our Business Plan Essentials series, experts sound off on building a marketing strategy that serves as a strategic blueprint for your business.

Here’s What Most Entrepreneurs Get Wrong About Marketing Strategy, Experts Say

In this fourth of five installments in our Business Plan Essentials series, experts share why finding the right people drives your company’s strategic direction and how to build a C-suite that's poised for growth.

How to Build a C-Suite That Scales, According to an Investor

In this third of five installments in our Business Plan Essentials series, experts explain how to gather credible data and synthesize these findings into compelling insights in order to make strategic decisions about the direction of your startup.

How to Use Competitive Intel to Boost Your Business Plan, According to Investors

In this second of five installments in our Business Plan Essentials series, you'll learn how to develop milestones that build momentum, guide progress, and help measure success.

How to Use Milestone Mapping to Chart a Path for Startup Growth

In this first of five installments in our Business Plan Essentials series, you'll learn why accurate financial projections are important, all the components of an effective business plan, and how to avoid common pitfalls. 

How to Build a Financial Roadmap for Your Business Plan

Accelerator director Dr. Mussaad M. Al-Razouki shares how the Cure by Deerfield Middle East Health Accelerator in Qatar can serve as a launchpad for trailblazing life sciences startups.

Inside Cure’s New Global Accelerator Program Empowering the Future of Healthcare

Whether pitching to angels, applying to accelerators, or negotiating venture capital, knowing the right funding terms can make or break your credibility as a healthcare founder. This guide breaks down the must-know concepts to help you speak the language of investors and secure the capital you need to grow.

The Language of Startup Funding: 35 Terms Every Founder Should Know 

With funding tightening, state governments are stepping up to support healthcare and life science startups with grants, incubator programs, and innovation funds. Here's how to determine if state funding can help your startup's research and growth.

Is State Funding Right For Your Startup? Image

Is State Funding Right For Your Startup?

For healthcare entrepreneurs, the right network is a source of capital, collaborators, clinical validation, and visibility. Our experts offer actionable tips for building relationships that will accelerate your startup’s mission.


7 Networking Strategies That Will Get You Funded, Validated, and Seen Image

7 Networking Strategies That Will Get You Funded, Validated, and Seen

From misaligned investor expectations to trial design pitfalls, healthcare entrepreneurs face obstacles on their road to growth. Experts from Rev1 Ventures and Vittoria Biotherapeutics share how to anticipate these challenges, and turn them into points of progress.

8 Early-Stage Hurdles Your Healthcare Startup Could Face—and How To Overcome Them Image

8 Early-Stage Hurdles Your Healthcare Startup Could Face—and How To Overcome Them

At a time when federal funding is shrinking, healthcare startups are finding critical support from mission-driven venture philanthropies like the ADDF and LLS willing to back early-stage, high-risk science.

Is Venture Philanthropy Right for Your Startup? Here’s How to Tell

CEOs of Veravas, Persephone Bioscience, and Citius Pharmaceuticals reveal what it takes to helm your own startup, the mistakes that can derail you, and how to know when it’s time to step aside.

Should You Be Your Healthcare Startup’s CEO? Founders Weigh In

Monica Cepak is redefining what it means to lead in healthcare. She’s transforming Wisp into a fearless, first-to-market platform for women’s sexual and reproductive health, normalizing taboo topics, and launching new verticals.  

Thumbnail-Monica Cepak-CEO-Wisp-1920x1080

13 Best Biotech and Life Sciences Conferences Taking Place In 2026

Meet the Founders, Investors, and Operators Joining the Cure Community

Your Home in NYC

Where Healthcare Innovators Connect

Accelerating Advances in Health

Sherri Gordon

31 Articles by Sherri Gordon